This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
4 Feb 2020

Colorcon starts No-Tox ink manufacturing at new UK facility

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Colorcon No-Tox Products, a leader in the design and manufacture of FDA and EU regulatory compliant specialty printing inks for direct and indirect contact with food, medical devices and pharmaceutical products has opened a new UK-based manufacturing facility to serve its growing customer base in Europe, the Middle East and Africa (EMEA).

With this new manufacturing capacity, Colorcon No-Tox is strengthening its presence in the European and UK markets and will provide its customers with shorter lead times and reduced transportation costs.

“We are excited to announce this important next step in our strategy to become an integral part of our customers’ supply chains,” said Simon Tasker, President, Colorcon Americas.

“Our new No-Tox plant in the UK, which is an extension of our existing pharmaceutical manufacturing plant in Dartford will allow us to serve our customers in increasingly better and more efficient ways by providing our high-quality regulatory compliant inks and coatings with close proximity to their markets and at lower transportation costs.”

David Bain, Managing Director, Colorcon Ltd added: “Our regional team is looking forward to supporting this next stage in the strategic market expansion of our Colorcon No-Tox specialty printing ink business. The plant will initially focus on regulatory compliant inks and coatings for direct and indirect food contact applications; such as those widely used in the plastic to paper straw conversion. The addition of medical and pharmaceutical inks and coatings will be extended through 2020.”

Mentioned Companies
Colorcon
View company profile

Related News